Listen to top surgeons discuss the expanding premium IOL landscape and crack the code for selecting presbyopia-correcting technologies.
Podcast Overview
Listen to top surgeons discuss the expanding premium IOL landscape and crack the code for selecting presbyopia-correcting technologies.
Language
🇺🇲
Publishing Since
12/30/2020
1 verified contact email on file for Presbyopia Unlocked
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
October 24, 2022
Expanding Presbyopia Treatment Options
Y. Ralph Chu, MD, welcomes Selina McGee, OD, FAAO, to discuss how the evaluation of presbyopia treatment options allows for more customized therapy for patients. The two explain how the presbyopia treatment landscape has evolved in recent years and how they talk to patients about all therapeutic options, including the recently FDA-approved Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan). Dr. McGee says that, with several different therapeutic options, she can tailor treatment based on a comprehensive eye examination and consultation about a patient’s lifestyle goals.
July 27, 2022
Expanding Treatment Options for Presbyopia
As the development of treatment options for presbyopia continues to expand, eye care providers could see an influx of new patients to their practices. In this episode, William B. Trattler, MD, moderates a discussion with Cecelia Koetting, OD, FAAO, and Justin Schweitzer, OD, FAAO, regarding how they educate and counsel patients about their approaches to presbyopia management. The panelists further discuss the opportunities that presbyopia drops such as Vuity (Allergan) provide their patients.
April 13, 2022
A Paradigm Shift in Presbyopia Management
Cathleen M. McCabe, MD, invites Daniel H. Chang, MD, and Rachael Wruble, OD, FAAO, to share their experiences with diagnosing and educating patients with presbyopia. The three physicians discuss some important factors to consider when talking with patients about their symptoms and impacts on their daily activities. They highlight how eye care providers should identify symptoms and educate patients at the earliest signs of presbyopia to inform them of all available treatment options.
9 total episodes available
Deep-dive analytics for Presbyopia Unlocked
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Presbyopia Unlocked?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.